|
Volumn 1, Issue 3, 2001, Pages 299-302
|
Management of spasticity, pain, and paroxysmal phenomena in multiple sclerosis.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
4 AMINOBUTYRIC ACID;
4 AMINOBUTYRIC ACID A RECEPTOR;
4 AMINOBUTYRIC ACID B RECEPTOR;
4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT;
ACETIC ACID DERIVATIVE;
AMINE;
BACLOFEN;
BENZODIAZEPINE DERIVATIVE;
BOTULINUM TOXIN A;
CANNABINOID;
CENTRAL MUSCLE RELAXANT;
CLONIDINE;
CYCLOHEXANECARBOXYLIC ACID DERIVATIVE;
DANTROLENE;
DRUG DERIVATIVE;
GABAPENTIN;
TIZANIDINE;
AUTOIMMUNE DISEASE;
CAUSALGIA;
DRUG EFFECT;
DYSTONIA;
HUMAN;
MECHANORECEPTOR;
MULTIPLE SCLEROSIS;
PAIN;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
PHYSIOTHERAPY;
RELAXATION TRAINING;
REVIEW;
SPASTICITY;
TRIGEMINUS NEURALGIA;
ACETIC ACIDS;
AMINES;
AUTOIMMUNE DISEASES;
BACLOFEN;
BENZODIAZEPINES;
BOTULINUM TOXIN TYPE A;
CANNABINOIDS;
CAUSALGIA;
CLONIDINE;
CYCLOHEXANECARBOXYLIC ACIDS;
DANTROLENE;
DYSTONIA;
GABA AGONISTS;
GAMMA-AMINOBUTYRIC ACID;
HUMANS;
MECHANORECEPTORS;
MULTIPLE SCLEROSIS;
MUSCLE RELAXANTS, CENTRAL;
MUSCLE SPASTICITY;
PAIN;
PHYSICAL THERAPY MODALITIES;
RECEPTORS, GABA-A;
RECEPTORS, GABA-B;
RELAXATION TECHNIQUES;
TRIGEMINAL NEURALGIA;
|
EID: 0035352341
PISSN: 15284042
EISSN: None
Source Type: Journal
DOI: 10.1007/s11910-001-0034-6 Document Type: Review |
Times cited : (21)
|
References (48)
|